The role of CD40 ligand in costimulation and T-cell activation

被引：373
作者：
Grewal, IS [1 ]
Flavell, RA [1 ]
机构：
[1] YALE UNIV, SCH MED, HOWARD HUGHES MED INST, IMMUNOBIOL SECT, NEW HAVEN, CT 06510 USA
来源：
IMMUNOLOGICAL REVIEWS | 1996年 / 153卷
关键词：
D O I：
10.1111/j.1600-065X.1996.tb00921.x
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：85 / 106
页数：22
相关论文
共 100 条
[1]   IMMUNE-RESPONSES ASSOCIATED WITH SUSCEPTIBILITY OF C57BL/10 MICE TO LEISHMANIA-AMAZONENSIS [J].
AFONSO, LCC ;
SCOTT, P .
INFECTION AND IMMUNITY, 1993, 61 (07) :2952-2959
[2]  
ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671
[3]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[4]   A DIFFERENTIAL-AVIDITY MODEL FOR T-CELL SELECTION [J].
ASHTONRICKARDT, PG ;
TONEGAWA, S .
IMMUNOLOGY TODAY, 1994, 15 (08) :362-366
[5]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[6]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[7]   THE EFFECT OF COMBINATION CYCLOSPORINE AND CTLA4-IG THERAPY ON CARDIAC ALLOGRAFT SURVIVAL [J].
BOLLING, SF ;
LIN, H ;
WEI, RQ ;
LINSLEY, P ;
TURKA, LA .
JOURNAL OF SURGICAL RESEARCH, 1994, 57 (01) :60-64
[8]  
BUHLMANN JE, 1995, IMMUNITY, V2, P645
[9]   CD40 LIGAND AND ITS ROLE IN X-LINKED HYPER-IGM SYNDROME [J].
CALLARD, RE ;
ARMITAGE, RJ ;
FANSLOW, WC ;
SPRIGGS, MK .
IMMUNOLOGY TODAY, 1993, 14 (11) :559-564
[10]   CD40 ligand is required for protective cell-mediated immunity to Leishmania major [J].
Campbell, KA ;
Ovendale, PJ ;
Kennedy, MK ;
Fanslow, WC ;
Reed, SG ;
Maliszewski, CR .
IMMUNITY, 1996, 4 (03) :283-289
12345678910